Geneos Wealth Management’s MacroGenics MGNX Stock Holding History

Geneos Wealth Management’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-100	Closed	-$2K	–	2954
2020 Q3	$2K	Hold	100	–	–	﹤0.01%	2423
2020 Q2	$2K	Sell	100 -1,500	-94%	-$26.1K	﹤0.01%	2368
2020 Q1	$9K	Hold	1,600	–	–	﹤0.01%	1857
2019 Q4	$17K	Sell	1,600 -400	-20%	-$3.96K	﹤0.01%	1758
2019 Q3	$24K	Hold	2,000	–	–	﹤0.01%	1523
2019 Q2	$33K	Buy	2,000 +400	+25%	+$6.87K	﹤0.01%	1395
2019 Q1	$28K	Buy	+1,600	New	+$27.7K	﹤0.01%	1413

Other funds holding MGNX

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Geneos Wealth Management's MGNX Position: Q4 2020 in Review

Geneos Wealth Management sold out of MacroGenics (MGNX) in Q4 2020, closing a stake of 100 shares — an estimated $2K sold.

Geneos Wealth Management first reported a position in MGNX in Q1 2019 and held it in 7 quarters. The position peaked at $33K in Q2 2019. 147 funds tracked by Wall St. Rank hold MGNX as of Q4 2020.

Geneos Wealth Management reported no remaining MacroGenics position as of Q4 2020 after selling out during the quarter.
Geneos Wealth Management sold 100 MacroGenics shares in Q4 2020, an estimated $2K.
Geneos Wealth Management first reported a position in MacroGenics in Q1 2019 and held it in 7 quarters.
Geneos Wealth Management's MacroGenics position peaked at $33K in Q2 2019.
147 funds tracked by Wall St. Rank held MacroGenics as of Q4 2020.

Based on Geneos Wealth Management's 13F filing for Q4 2020, filed 19 May 2021.